Neuronetics Days Of Inventory On Hand from 2010 to 2024

STIM Stock  USD 0.84  0.04  5.00%   
Neuronetics Days Of Inventory On Hand yearly trend continues to be very stable with very little volatility. Days Of Inventory On Hand is likely to drop to 100.74. During the period from 2010 to 2024, Neuronetics Days Of Inventory On Hand quarterly data regression pattern had sample variance of  1,891 and median of  93.48. View All Fundamentals
 
Days Of Inventory On Hand  
First Reported
2010-12-31
Previous Quarter
150.38156086
Current Value
100.74
Quarterly Volatility
43.48187726
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Neuronetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuronetics' main balance sheet or income statement drivers, such as Interest Income of 3.3 M, Depreciation And Amortization of 1.4 M or Interest Expense of 4.2 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.0 or PTB Ratio of 1.94. Neuronetics financial statements analysis is a perfect complement when working with Neuronetics Valuation or Volatility modules.
  
Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

Latest Neuronetics' Days Of Inventory On Hand Growth Pattern

Below is the plot of the Days Of Inventory On Hand of Neuronetics over the last few years. It is Neuronetics' Days Of Inventory On Hand historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neuronetics' overall financial position and show how it may be relating to other accounts over time.
Days Of Inventory On Hand10 Years Trend
Slightly volatile
   Days Of Inventory On Hand   
       Timeline  

Neuronetics Days Of Inventory On Hand Regression Statistics

Arithmetic Mean111.27
Geometric Mean105.08
Coefficient Of Variation39.08
Mean Deviation31.76
Median93.48
Standard Deviation43.48
Sample Variance1,891
Range144
R-Value0.52
Mean Square Error1,485
R-Squared0.27
Significance0.05
Slope5.06
Total Sum of Squares26,469

Neuronetics Days Of Inventory On Hand History

2024 100.74
2023 150.38
2022 209.79
2021 205.57
2020 117.52
2019 65.82
2018 71.32

About Neuronetics Financial Statements

Neuronetics investors utilize fundamental indicators, such as Days Of Inventory On Hand, to predict how Neuronetics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 150.38  100.74 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:
Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.22)
Revenue Per Share
2.453
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.17)
Return On Equity
(1.00)
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.